• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Addiction Treatment Forum

Addiction Treatment Forum

Addiction Treatment Forum reports on substance use news of interest to opioid treatment programs and patients in medication-assisted treatment.

  • Newsletter
  • Addiction Resources
  • Methadone
  • Buprenorphine
  • Patient Brochures
  • Events

Methadone, buprenorphine, gabapentin used nonmedically: Study

August 17, 2022 by Alison Knopf

A recent study has found that gabapentin is being used nonmedically in conjunction with nonmedical methadone or buprenorphine to reduce withdrawal symptoms. For the study, based on two nationwide opioid surveillance programs of treatment-seeking individuals with opioid use disorder (OUD), the researchers wanted to systematically assess the relationship between the nonmedical use of gabapentin and agonist medications used to treat OUD. For the study, 9.3% of the OUD sample reported past month nonmedical use of gabapentin. Of those, 64.1% were using either buprenorphine (49.0%) or methadone (35.3%) nonmedically. The use of gabapentin and the other two drugs was higher in chronic pain, homeless, and healthcare professionals. Nonmedical use of gabapentin in people with OUD appears to frequently coincide with nonmedical use of buprenorphine and methadone, the researchers concluded. They also urge that treatment providers be educated about the risks of gabapentin, stressing that this should particularly be known by buprenorphine prescribers. They suggested that within the context of OUD treatment access and retention, motivations for nonmedical use, including efforts to avoid withdrawal. Methadone is Schedule II on the Controlled Substances Act, the most restrictive category of legal medications; buprenorphine is Schedule III; gabapentin is currently unscheduled by the federal government, but some states do consider it a controlled substance so they can track prescriptions on the PDMP. Ellis MS, Buttram ME, Kasper ZA: Nonmedical use of gabapentin and opioid agonist medications in treatment-seeking individuals with opioid use disorder. Drug Alcohol Depend. 2022 May 1;234:109400.

 doi: 10.1016/j.drugalcdep.2022.109400. Epub 2022 Mar 9.

Filed Under: 2022, Newsletter

Primary Sidebar

Upcoming Events

CADCA 2023 Leadership Forum and SAMHSA’s Prevention Day
January 30-February 3, 2023

Washington, D.C.
http://cadca.org/forum2023

2023 Rx and Illicit Drug Summit
April 10-13, 2023

Atlanta, Georgia
https://www.rx-summit.com/

2023 ASAM conference
April 13-16, 2023

Washington, D.C.
https://annualconference.asam.org/

 

View More Upcoming Events…

ATForum.com

  • Newsletter
  • Addiction Resources
  • Rx Methadone & Safety
  • Patient Education Brochures
  • Events
  • Related Websites

Addiction Resources

  • Addiction and Recovery
  • Addiction Treatment Forum
  • Books and Booklets of Interest
  • Drug Screening and Testing
  • Evidence-Based Addiction Medicine
  • Federal Government
  • Health Care Reform
  • Hepatitis, HIV/AIDS
  • Medication-Assisted Treatment
  • Mental Health
  • Miscellaneous
  • Online Continuing Education Free Training Modules

Footer

Addiction Treatment Forum is produced by an independent medical communications agency. Commercial advertising is not accepted.
Published by Clinco Communications, Inc.
About Us
Contact Us
Privacy Policy
Terms of Use
Follow Us

Sign up for News!

© 2023 Addiction Treatment Forum · All Rights Reserved